Locations:
Min Investment:
Max Investment:
Target Investment:
(2001 - 2002)
(1995 - 2001)
2023
2023
iOnctura is a clinical stage biopharmaceutical company dedicated to delivering innovative cancer treatments to patients with unmet medical need.
2016
2023
2019 - 2022
2016 - 2018
2022
2022
Calypso Biotech is an immunotherapy biotech company, spin-off from Merck Serono, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs
2022
TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
2019
Discovery and development of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss
2018
2018
Castor EDC is a user-friendly Electronic Data Capture platform being used by medical researchers worldwide. With the help of its system, Castor allows researchers to streamline the clinical trial process and use their data to its full potential.
2016
2018
2016 - 2018
2019 - 2022
2019 - 2022
Aidence develops and markets AI-enabled automated analysis medical images analysis used by healthcare specialists to help their patients. Acquired by RadNet.
2019 - 2020
2019 - 2020
First in class anti-FGFR3 mAb for the treatment of advanced bladder cancer. Assets acquired by Fusion Pharma
2010 - 2016
2010 - 2016